Genprex, Inc.(GNPX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GNPX Genprex, Inc.

盘前交易 08-14 04:00:44 EDT

4.87

+0.14

+2.96%

最高5.24	最低4.68	成交量10.36万
今开4.69	昨收4.73	日振幅11.78%
总市值245.89万	流通市值239.99万	总股本50.49万
成交额51.69万	换手率21.02%	流通股本49.28万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GNPX","market":"US","secType":"STK","nameCN":"Genprex, Inc.","latestPrice":4.87,"timestamp":1786651200000,"preClose":4.73,"halted":0,"volume":103583,"delay":0,"changeRate":0.02959830866807604,"floatShares":492786,"shares":504900,"eps":-349.9386,"marketStatus":"盘前交易","change":0.14,"latestTime":"08-14 04:00:44 EDT","open":4.69,"high":5.2373,"low":4.68,"amount":516878.341336,"amplitude":0.117822,"askPrice":6.99,"askSize":55,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-349.9386,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786714200000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1522296000000,"exchange":"NASDAQ","adjPreClose":4.87,"postHourTrading":{"tag":"盘后","latestPrice":5.05,"preClose":4.87,"latestTime":"19:34 EDT","volume":9385,"amount":47965.7514,"timestamp":1786664046871,"change":0.18,"changeRate":0.036961,"amplitude":0.104661},"volumeRatio":0.8975747640357957,"impliedVol":3.1839,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/GNPX","defaultTab":"news","newsList":[{"id":"1182022854","title":"Reqorsa®基因疗法生物标志物积极临床数据于2026年ASCO年会公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1182022854","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1182022854?lang=zh_cn&edition=full","pubTime":"2026-05-26 20:01","pubTimestamp":1779796880,"startTime":"0","endTime":"0","summary":"在2026年美国临床肿瘤学会（ASCO）年会上，有关Reqorsa®基因疗法在患者体内生物标志物的积极临床数据正式发布。该数据揭示了治疗过程中关键分子指标的变化趋势，为评估疗法作用机制与潜在疗效提供了重要依据。研究显示，接受治疗的患者在多类生物标志物上呈现一致且具有统计学意义的改善，这进一步支持了该基因疗法的生物学活性及其对目标通路的有效调控。此次公布的数据强化了Reqorsa®在相关治疗领域中的开发前景，并为后续临床研究设计奠定了科学基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNPX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191211565","title":"Reqorsa®基因疗法生物标志物临床数据积极，将于2026年ASCO年会公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1191211565","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191211565?lang=zh_cn&edition=full","pubTime":"2026-04-22 19:04","pubTimestamp":1776855889,"startTime":"0","endTime":"0","summary":"备受期待的Reqorsa®基因疗法在患者生物标志物方面的积极临床数据，即将在2026年美国临床肿瘤学会（ASCO）年会上正式发布。\n这项关键数据的公布，预计将为评估该基因疗法的疗效与作用机制提供重要依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNPX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155315638","title":"Genprex签署资助研究协议 探索可预测患者对Reqorsa®基因疗法反应的生物标志物","url":"https://stock-news.laohu8.com/highlight/detail?id=1155315638","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1155315638?lang=zh_cn&edition=full","pubTime":"2026-04-21 19:02","pubTimestamp":1776769374,"startTime":"0","endTime":"0","summary":"Genprex公司已正式签署一项资助研究协议，旨在系统研究可能预测患者对Reqorsa®基因疗法治疗反应的生物标志物。该研究将深入分析特定分子指标，以期建立更精准的患者响应预测模型，为个性化治疗方案提供科学依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GNPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614852714","title":"Genprex, Inc.盘中异动 股价大跌6.10%报2.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614852714","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2614852714?lang=zh_cn&edition=full","pubTime":"2026-02-27 22:56","pubTimestamp":1772204163,"startTime":"0","endTime":"0","summary":"北京时间2026年02月27日22时56分，Genprex, Inc.股票出现异动，股价大幅下挫6.10%。截至发稿，该股报2.00美元/股，成交量10.177万股，换手率4.48%，振幅6.24%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Genprex, Inc.公司简介：Genprex Inc 是一家处于临床阶段的基因治疗公司，专注于为癌症和糖尿病患者开发能够改变生活的疗法。Genprex 的肿瘤学项目利用其系统性、非病毒的Oncoprex递送系统，该系统采用基于脂质的纳米颗粒以脂质体复合物的形式包裹表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022722560495424c28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022722560495424c28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612744292","title":"Genprex, Inc.盘中异动 股价大涨6.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612744292","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2612744292?lang=zh_cn&edition=full","pubTime":"2026-02-18 23:51","pubTimestamp":1771429863,"startTime":"0","endTime":"0","summary":"北京时间2026年02月18日23时51分，Genprex, Inc.股票出现波动，股价快速上涨6.08%。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Genprex, Inc.公司简介：Genprex Inc 是一家处于临床阶段的基因治疗公司，专注于为癌症和糖尿病患者开发能够改变生活的疗法。Genprex 的肿瘤学项目利用其系统性、非病毒的Oncoprex递送系统，该系统采用基于脂质的纳米颗粒以脂质体复合物的形式包裹表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260218235103a4b0ba3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260218235103a4b0ba3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611189991","title":"Genprex, Inc.盘中异动 大幅跳水6.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611189991","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2611189991?lang=zh_cn&edition=full","pubTime":"2026-02-12 23:02","pubTimestamp":1770908574,"startTime":"0","endTime":"0","summary":"北京时间2026年02月12日23时02分，Genprex, Inc.股票出现异动，股价快速下跌6.36%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Genprex, Inc.公司简介：Genprex Inc 是一家处于临床阶段的基因治疗公司，专注于为癌症和糖尿病患者开发能够改变生活的疗法。Genprex 的肿瘤学项目利用其系统性、非病毒的Oncoprex递送系统，该系统采用基于脂质的纳米颗粒以脂质体复合物的形式包裹表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602122302549540ee7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602122302549540ee7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143451319","title":"Genprex宣布澳大利亚知识产权局拟授予Reqorsa®基因疗法联合PD-L1抗体治疗癌症专利","url":"https://stock-news.laohu8.com/highlight/detail?id=1143451319","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143451319?lang=zh_cn&edition=full","pubTime":"2026-02-10 21:05","pubTimestamp":1770728721,"startTime":"0","endTime":"0","summary":"Genprex公司今日披露，澳大利亚知识产权局已表达授予其专利的意向，该专利涵盖其研发的Reqorsa®基因疗法与PD-L1抗体联合使用的治疗方案，旨在攻克多种癌症。这一重要进展标志着公司在肿瘤治疗领域的创新技术获得国际权威认可，为后续临床开发与商业化奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNPX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514522378","title":"Genprex, Inc.盘中异动 大幅上涨5.33%报0.395美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514522378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514522378?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:38","pubTimestamp":1740753502,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时38分，Genprex, Inc.股票出现异动，股价大幅拉升5.33%。截至发稿，该股报0.395美元/股，成交量4.8375万股，换手率0.57%，振幅1.39%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223822a2580314&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223822a2580314&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514851687","title":"Genprex, Inc.盘中异动 早盘股价大涨5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514851687","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514851687?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:53","pubTimestamp":1740581593,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时53分，Genprex, Inc.股票出现波动，股价大幅上涨5.44%。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226225313a254fc08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226225313a254fc08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513656773","title":"Genprex, Inc.盘中异动 早盘急速下挫5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513656773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513656773?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:47","pubTimestamp":1740412041,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时47分，Genprex, Inc.股票出现波动，股价快速下挫5.88%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224234722a2522674&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224234722a2522674&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512848369","title":"Genprex, Inc.盘中异动 早盘大幅下挫5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512848369","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512848369?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:44","pubTimestamp":1739976264,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时44分，Genprex, Inc.股票出现波动，股价急速跳水5.27%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219224424988b33e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219224424988b33e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512165056","title":"Genprex, Inc.盘中异动 股价大跌5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165056","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512165056?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:31","pubTimestamp":1739889100,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时31分，Genprex, Inc.股票出现波动，股价大幅跳水5.65%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223140a24aac82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223140a24aac82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511851526","title":"Genprex, Inc.股价拉升12.82% 市值涨58.55万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511851526","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511851526?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:31","pubTimestamp":1739457068,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时31分，Genprex, Inc.股票出现异动，股价大幅拉升12.82%。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Tc Biopharm  Plc、Edesa Biotech, Inc.、Genprex, Inc.较为活跃，换手率分别为970.17%、765.03%、89.78%，振幅较大的相关个股有Enliven Therapeutics, Inc.、Rezolute, Inc.、Edesa Biotech, Inc.，振幅分别为7.80%、4.53%、4.03%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223108abcdb1e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223108abcdb1e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509327701","title":"Genprex, Inc.盘中异动 早盘大幅上涨5.80%报0.529美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509327701","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509327701?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:31","pubTimestamp":1738852272,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时31分，Genprex, Inc.股票出现异动，股价大幅上涨5.80%。截至发稿，该股报0.529美元/股，成交量3.3096万股，换手率0.39%，振幅0.00%。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223112987c8e9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223112987c8e9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508457753","title":"Genprex, Inc.股价重挫12.31% 市值跌5.99万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508457753","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508457753?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:33","pubTimestamp":1738679597,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时33分，Genprex, Inc.股票出现异动，股价急速跳水12.31%。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223317a239292e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223317a239292e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508312834","title":"Genprex, Inc.盘中异动 早盘大幅下挫5.08%报0.587美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508312834","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508312834?lang=zh_cn&edition=full","pubTime":"2025-02-04 00:21","pubTimestamp":1738599689,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日00时21分，Genprex, Inc.股票出现异动，股价急速下跌5.08%。截至发稿，该股报0.587美元/股，成交量6.223万股，换手率0.73%，振幅6.13%。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为0.53%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204002129abc11e6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204002129abc11e6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506951709","title":"Genprex, Inc.盘中异动 股价大涨5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506951709","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506951709?lang=zh_cn&edition=full","pubTime":"2025-01-28 23:24","pubTimestamp":1738077868,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日23时24分，Genprex, Inc.股票出现异动，股价大幅上涨5.28%。截至发稿，该股报0.640美元/股，成交量5.4322万股，换手率0.64%，振幅8.88%。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501282324299612faac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501282324299612faac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506914308","title":"Genprex, Inc.盘中异动 早盘快速下跌7.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506914308","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506914308?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:33","pubTimestamp":1737988383,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时33分，Genprex, Inc.股票出现异动，股价急速跳水7.13%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012722330496123997&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012722330496123997&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505776825","title":"Genprex, Inc.盘中异动 大幅拉升6.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505776825","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505776825?lang=zh_cn&edition=full","pubTime":"2025-01-23 01:10","pubTimestamp":1737565843,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日01时10分，Genprex, Inc.股票出现波动，股价大幅上涨6.01%。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123011044986f9181&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123011044986f9181&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503624061","title":"Genprex, Inc.盘中异动 股价大跌5.15%报0.700美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503624061","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503624061?lang=zh_cn&edition=full","pubTime":"2025-01-16 00:42","pubTimestamp":1736959374,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日00时42分，Genprex, Inc.股票出现波动，股价急速跳水5.15%。截至发稿，该股报0.700美元/股，成交量7.8195万股，换手率0.92%，振幅4.66%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.91%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501160042549604d31f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501160042549604d31f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.genprex.com","stockEarnings":[{"period":"1week","weight":0.0968},{"period":"1month","weight":-0.5221},{"period":"3month","weight":-0.7334},{"period":"6month","weight":-0.8904},{"period":"1year","weight":-0.9803},{"period":"ytd","weight":-0.8735}],"compareEarnings":[{"period":"1week","weight":0.0121},{"period":"1month","weight":0.0346},{"period":"3month","weight":0.0524},{"period":"6month","weight":0.141},{"period":"1year","weight":0.2062},{"period":"ytd","weight":0.1407}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Genprex, Inc.于2009年4月在特拉华州注册成立。该公司是一家私人持有的临床阶段生物制药公司，为癌症开发免疫原性治疗。Genprex是一种临床阶段的基因治疗公司，开发一种新的方法来治疗癌症，根据其新的专利技术平台，包括其最初的候选产品，Oncoprex免疫基因治疗提供，或Oncoprex。他们的平台技术旨在通过将其包封在称为纳米囊泡的纳米尺度空心球体中来治疗癌症基因，然后静脉内施用并被肿瘤细胞摄取，其中它们表达缺少或发现量低的蛋白质。 Oncoprex具有多模式作用机制，其中断细胞信号通路，其引起癌细胞的复制和增殖，重新建立癌细胞中凋亡途径或程序性细胞死亡途径，并调节针对癌细胞的免疫应答。 Oncoprex也被证明可以阻断产生耐药性的机制。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.715067},{"month":2,"riseRate":0.375,"avgChangeRate":0.036692},{"month":3,"riseRate":0.125,"avgChangeRate":-0.190199},{"month":4,"riseRate":0.333333,"avgChangeRate":0.147889},{"month":5,"riseRate":0.444444,"avgChangeRate":0.015712},{"month":6,"riseRate":0.222222,"avgChangeRate":-0.166779},{"month":7,"riseRate":0.222222,"avgChangeRate":-0.179652},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.140756},{"month":9,"riseRate":0.125,"avgChangeRate":-0.162406},{"month":10,"riseRate":0.125,"avgChangeRate":0.45127},{"month":11,"riseRate":0.125,"avgChangeRate":-0.228987},{"month":12,"riseRate":0.375,"avgChangeRate":-0.063233}],"exchange":"NASDAQ","name":"Genprex, Inc.","nameEN":"Genprex, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Genprex, Inc.(GNPX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Genprex, Inc.(GNPX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Genprex, Inc.,GNPX,Genprex, Inc.股票,Genprex, Inc.股票老虎,Genprex, Inc.股票老虎国际,Genprex, Inc.行情,Genprex, Inc.股票行情,Genprex, Inc.股价,Genprex, Inc.股市,Genprex, Inc.股票价格,Genprex, Inc.股票交易,Genprex, Inc.股票购买,Genprex, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Genprex, Inc.(GNPX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Genprex, Inc.(GNPX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}